MedPath

An Observational Cohort Study to Establish Accurate Nutrition Therapy for Critically Ill Patients

Conditions
Nutrition Therapy for Critical Illness
Registration Number
NCT02831725
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

1. Demographics data;

2. Nutritional evaluation data;

3. All biochemical monitoring data during the study period;

4. All nutritional treatment data will be recorded daily during the study period, including actual calorie intake, protein intake, and the proportion of calorie/protein administered by EN and/or PN route. The nutritional treatment protocol will be decided by the attending physician, the investigator will not intervene.

5. A blood sample (5 ml) will be drawn from every patient immediately after they enroll into the study, and the metabolomics of the samples will be analyzed analysis using a combined 800 MHz 1H-NMR-UPLC-MS system. The data will then be used to establish metabolic profile baseline.

6. We will establish a sub-group that contains 20 patients (chosen from enrolled patients according to APACHE II scores: 10 patients are APACHE II scores in 21-30). We will take one blood sample daily during the whole study period. The plasma sample will be used for metabolomics analysis using an 800 MHz 1H-NMR-UPLC-MS system. And the data will be used for metabolic dynamic modeling.

7. Clinical outcomes data, which include: 1) Complications after the operation (intestinal fistula, pancreatic fistula, biliary fistula and sepsis, bleeding, nosocomial infection); 2) death event; 3) ICU-stay; 4) Length of hospitalization

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • age: 18-70
  • patients are underwent Whipple operation or subtotal gastrectomy and ever admitted to intensive care unit (ICU) after the operation
  • receive parenteral or enteral nutrition > 3 days
Exclusion Criteria
  • has metabolic disorders: diabetes, thyroid disease
  • Pregnant or breastfeeding
  • The presence of drug or alcohol dependence
  • The presence of tuberculosis, HIV infection and other acute infectious disease
  • Serious liver, kidney, heart and other vital organ failure

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
complications after the operationthree years

intestinal fistula, pancreatic fistula, biliary fistula and sepsis, bleeding, nosocomial infection

Secondary Outcome Measures
NameTimeMethod
Ā© Copyright 2025. All Rights Reserved by MedPath